Overview
Xenico Pharma produces pharmaceutical preparations and supplements containing vitamins, iron and plant extracts. Its products include bergamot extract, vitamins K2+D3 and D3, and a blend of extracts from three types of ginseng.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2022, 19 days late).
- 2025filed
- 202414/07/2025
- 202305/02/2024
- 202203/08/2023
- 202128/06/2022
- 202028/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Xenico Pharma holds 4 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2016.
| Mark | Protected until | |
|---|---|---|
| Manuka C 1000 Xenico(word) | Jul 10, 2029 | |
| Visionex Duo(word) | Jun 10, 2036 | |
| Menachinox K2(word) | Jun 10, 2036 | |
| Xenimag(word) | Jun 10, 2036 | |
| Monolipid K(word) | – |
Authorized Representatives
Manner of representation
For disposing of rights and incurring liabilities on behalf of the company, the President of the Management Board is authorized independently, while a member of the management board is authorized to dispose of rights and incur liabilities on behalf of the company independently up to the amount of PLN 100,000, and above the amount of PLN 100,000 jointly with the President of the Management Board. For making declarations on behalf of the company in non-property matters, each member of the management board is authorized to act independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Radosław Sewerynage 41 | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-05-11.
83 1090 2590 0000 0001 4167 1659- 57 1090 2590 0000 0001 4480 0377
- 34 1090 2590 0000 0001 4281 7723
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $164.7K$164,741 |
Buildings and premises | $759K$758,958 |
Public aid
7 public aid cases recorded, with a total value of $166,904.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 2, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $21,070$21,070 | Prezes Banku Gospodarstwa Krajowego | |
| Sep 8, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,005$1,005 | Prezes Banku Gospodarstwa Krajowego | |
| Aug 30, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,002$1,002 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Exim Pharmasp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| Biovena Healthsp. z o.o. | $6,016,230.67 | biovenahealth.com | ||
| Langsteinersp. z o.o. | $4,412,556.80 | langsteiner.eu | ||
| Uropharmasp. z o.o. | $1,113,812.65 | uroplus.pl | ||
| Symbio-Labsp. z o.o. | $920,360.37 | symbio-lab.com | ||
| Natur DayS.A. | $680,635.59 | naturday.pl |
FAQ
Last updated: 2026-10-07